Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Challenges to Hematopoietic Stem Cell Research Today]

Pei-Hsien Tang

    Zhongguo Shi Yan Xue Ye Xue Za Zhi
    |February 13, 2003
    PubMed
    Summary

    Hematopoietic stem cell research explores CD34(-) cell precursors and CD34(+) cell engraftment. Advances in HLA typing and unrelated donor transplants are crucial for improving patient outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Functional and Phenotypic Alteration of Intrasplenic Lymphocytes Affected by Mesenchymal Stem Cells in a Murine Allosplenocyte Transfusion Model.

    Cell transplantation·2017
    Same author

    Functional and phenotypic alteration of intrasplenic lymphocytes affected by mesenchymal stem cells in a murine allosplenocyte transfusion model.

    Cell transplantation·2007
    Same author

    [Osteoblasts derived from mesenchymal stem cells harbor immunoregulatory effect].

    Zhongguo shi yan xue ye xue za zhi·2005
    Same author

    Certain new progresses in experimental hematology in China and more queries on mesenchymal stem cell research.

    Chinese medical journal·2004
    Same author

    Comparison of mesenchymal stem cells from human placenta and bone marrow.

    Chinese medical journal·2004
    Same author

    Controversy on adult stem-cell plasticity and rules governing the use of fetal tissue in China.

    The Journal of laboratory and clinical medicine·2004

    Area of Science:

    • Hematology
    • Immunology
    • Stem Cell Biology

    Background:

    • Human CD34(-) cells are potential precursors to CD34(+) cells, which are known for long-term hematopoietic reconstitution.
    • The precise role of CD34(-) and Lineage-negative (Lin-) cells as optimal stem cells remains uncertain.
    • Current negative selection techniques for CD34(-) cells limit definitive characterization.

    Purpose of the Study:

    • To investigate the characteristics and potential of CD34(-) cells in hematopoiesis.
    • To analyze factors influencing stem cell engraftment, including cell dose and HLA matching.
    • To evaluate the efficacy and challenges of different stem cell transplantation strategies.

    Main Methods:

    • Analysis of existing literature on CD34(-) and CD34(+) cell populations.
    • Review of clinical data on stem cell engraftment predictors, including cell numbers and umbilical cord blood (UCB) infusion criteria.
    • Examination of HLA typing methodologies (serology vs. DNA-based genotyping) and their impact on transplant outcomes.
    • Assessment of unrelated donor transplantation strategies, including matched and mismatched scenarios.

    Main Results:

    • CD34(+) enriched populations demonstrate proven long-term hematopoietic reconstitution.
    • Successful engraftment is critically dependent on the number of infused cells, with specific cell counts recommended for UCB and mobilized peripheral blood.
    • Delayed engraftment and malignancy relapse are challenges in UCB transplantation, though it remains optimal for non-malignant pediatric cases.
    • DNA-based HLA typing offers higher resolution and is recommended for increased accuracy, particularly in unrelated donor/recipient pairs.
    • A significant unmet need exists for suitable stem cell donors, especially in China, highlighting the importance of unrelated donor transplants.

    Conclusions:

    • Further research is needed to fully characterize CD34(-) and CD34(-)/Lin(-) cells, requiring highly purified populations.
    • Optimizing cell dose and HLA matching are critical for successful stem cell transplantation.
    • Unrelated donor transplantation, including mismatched options, is a vital strategy for patients lacking related donors.
    • Advancements in stem cell biology and clinical practices, particularly in HLA typing and donor selection, are expected to drive significant progress in the field.

    Related Experiment Videos